openPR Logo
Press release

Global Leukemia Therapeutic Market Research and Forecast 2018-2023

03-11-2019 11:32 AM CET | Health & Medicine

Press release from: Orion Market Research

Global Leukemia Therapeutic Market Research and Forecast

Recently, Orion Market Research (OMR) published a market research report on the global leukemia therapeutics market which is expected to grow significantly during the forecast period 2018-2023. North America is further analyzed as the US and Canada; Europe as the UK, Germany, Italy, Spain, and Rest of Europe; and Asia-Pacific as India, China, Japan, and Rest of the Asia-Pacific. North America and Europe generate the highest revenues across the globe due to a huge number of leukemia patients and the highest rate of healthcare spending. Asia-Pacific region such as China, India, Japan, and Korea are predicted to offer a variety of opportunities for the leukemia market due to improved healthcare spending, infrastructure, and favorable government policies.

A full report of the global leukemia therapeutics market is available at https://www.omrglobal.com/industry-reports/leukemia-therapeutics-market/

Furthermore, the global leukemia therapeutics market is segmented on the basis of type, and drugs type. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Market Segmentation

1. Global Leukemia Therapeutics Market by Type
• Acute Myeloid Leukemia
• Chronic Myeloid Leukemia
• Acute Lymphocytic Leukemia
• Chronic Lymphocytic Leukemia
2. Global Leukemia Therapeutics Market by Drugs Type
• Acute Lymphoblastic Leukemia Drugs
• Myelogenous Leukemia Drug
• Chronic Lymphocytic Leukemia Drug
• Acute Promyelocytic Leukemia Drug
• Other Drugs

Region Covered

• North America (the US and Canada)
• Europe (United Kingdom, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the World (the Middle East & Africa and Latin America)

Company Profiled

• Abbott Laboratories, Inc.
• Agios Pharmaceuticals
• Ambit Biosciences
• Astellas Pharma Inc.
• Biogen, Inc.
• Bristol-Myers Squibb Co.
• Celgene Corp.
• Cephalon
• Clavis Pharma ASA
• Eisai Co., Ltd.
• Genzyme Corp.
• GlaxoSmithKline PLC
• Innate Pharma
• Johnson & Johnson Services, Inc.
• Merck & Co.
• Novartis AG
• Pfizer, Inc.
• Roche Holdings AG
• Sunesis Pharmaceuticals, Inc.
• Talon Therapeutics, Inc.

For related reports please visit https://www.omrglobal.com/reports-category/pharmaceuticals/

For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/

About Orion Market Research

Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Contact us

Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com
India: +91 7803040404
Global:+1 6467557667
Indore-India-452010
Web: www.omrglobal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Leukemia Therapeutic Market Research and Forecast 2018-2023 here

News-ID: 1645388 • Views:

More Releases from Orion Market Research

Workplace Safety Market Set to Witness Significant Growth by 2033 | MSA Safety Incorporated, Ansell Limited, Drägerwerk AG & Co. KGaA
Workplace Safety Market Set to Witness Significant Growth by 2033 | MSA Safety I …
The Workplace Safety market was valued at approximately USD 16.2 billion in 2024 and is projected to reach around USD 49.4 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.20% from 2025 to 2033. Workplace Safety Market Overview The global Workplace Safety market is experiencing significant growth, driven by increasing awareness of occupational hazards, stricter regulations, and a heightened focus on employee well-being. Employers are emphasizing
Waste Sorting Robots Market Set to Witness Significant Growth by 2033 | Bulk Handling Systems (BHS), Sadako Technologies
Waste Sorting Robots Market Set to Witness Significant Growth by 2033 | Bulk Han …
The global Waste Sorting Robots market was valued at approximately USD 2.13 billion in 2024 and is projected to reach around USD 10.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 19.6% from 2025 to 2033. Waste Sorting Robots Market Overview The global Waste Sorting Robots market is experiencing significant growth, driven by increasing environmental concerns, stringent waste management regulations, and the need for efficient and cost-effective
Food Blenders & Mixers Market Set to Witness Significant Growth by 2034 | Bühler Group, John Bean Technologies (JBT), and KHS Group
Food Blenders & Mixers Market Set to Witness Significant Growth by 2034 | Bühl …
The global Food Blenders & Mixers market was valued at approximately USD 10.08 billion in 2024 and is projected to reach around USD 19.29 billion by 2034, expanding at a compound annual growth rate (CAGR) of 6.70% from 2025 to 2034. Food Blenders & Mixers Market Overview The global Food Blenders & Mixers market is experiencing significant growth, driven by advancements in food processing technologies and increasing consumer demand for convenience
Artificial Intelligence (AI) in Cybersecurity Market Set to Witness Significant Growth by 2033 | FireEye, Inc., Check Point Software Technologies Ltd
Artificial Intelligence (AI) in Cybersecurity Market Set to Witness Significant …
The global Artificial Intelligence (AI) in Cybersecurity market was valued at approximately USD 25.35 billion in 2024. its robust expansion, with estimates suggesting it could attain USD 240.42 billion by 2033, reflecting a CAGR of 26.3% from 2025 to 2033. Artificial Intelligence (AI) in Cybersecurity Market Overview The AI in Cybersecurity market is experiencing rapid growth due to the increasing sophistication of cyber threats and the need for advanced defense mechanisms.

All 5 Releases


More Releases for Leukemia

The Impact Of Increasing Leukemia Prevalence On The Leukemia Therapeutics Market …
The Leukemia Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Leukemia Therapeutics Market Size During the Forecast Period? In recent times, the market size for leukemia therapeutics has seen robust growth. It is projected to increase from $17.57 billion in 2024
Leukemia Therapeutics Market - Revolutionizing Leukemia Care: Cutting-Edge Thera …
Newark, New Castle, USA: The "Leukemia Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Leukemia Therapeutics Market: https://www.growthplusreports.com/report/leukemia-therapeutics-market/7759 This latest report researches the industry structure, sales, revenue,
Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, T …
Orbisreserach.Com Adds “H1 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Market Pipeline Review 2017 Trend Analysis Report Report” To Its Research Database Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2017, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) (Oncology) pipeline landscape. Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a type of cancer that starts in the blood-forming cells of the
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to